Navigation Links
Middle East Pharma Manufacturing/Biotech is Ready to Boom
Date:9/4/2007

Middle East's only forum for the global pharma/biotech industries Pharmaceutical Manufacturing and Biotechnology Middle East (PABME) 27-29

April 2008

DUBAI, United Arab Emirates, Sept. 4 /PRNewswire/ -- The Middle East market for pharmaceutical manufacturing and biotechnology, already valued at over US$ 28 billion and with annual growth in double digits. The market drivers are:

-- Dubai is the commercial, scientific and financial center of the region

-- Healthcare infrastructure is a major priority with 12%-15% annual

growth

-- Surplus of funds to invest in pharma and biotechnology enterprises

-- DUBIOTECH, a free trade zone that is attracting world-class life

science enterprises

Pharmaceutical Manufacturing and Biotechnology Middle East (PABME) is the first major meeting and exhibition to enable access to the Middle East market. It is planned to attract the critical mass of individuals in the sciences, business, finance and manufacturing.

For more details visit http://www.scherago.com/pabme or email herbb@scherago.com

About Scherago International (http://www.scherago.com)

Scherago International (SI) brings over 30 year's experience in the development, organizing and marketing of shows in the biotechnology and healthcare markets. SI serves as the PABME agent in the Americas, Canada, Scandinavia, Benelux, Spain, Italy, Korea and Japan.

Contact: Herb Burklund

Tel: +1-201-653-4777

Fax: +1-201-653-5705

eMail: herbb@scherago.com


'/>"/>
SOURCE Scherago International
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Amendia, Inc., a ... procedures, today announced the completion of a significant transaction and partnership that positions ... customers and partners. Kohlberg & Company, L.L.C. (“Kohlberg”), a leading private equity ...
(Date:4/29/2016)... and San Diego, CA (PRWEB) , ... April 29, 2016 , ... ... Stem Cell Foundation (NSCF) to support the development of a patient-specific stem cell therapy ... Andrés Bratt-Leal in the lab of Dr. Jeanne Loring at The Scripps Research Institute ...
(Date:4/28/2016)... , April 28, 2016 ... Stirling, and Brayton Cryocoolers), Service (Technical Support, Product Repairs ... Geography - Global Forecast to 2022", published by MarketsandMarkets, ... 2.94 Billion by 2022, at a CAGR of 7.29% ... market data Tables and 94 Figures spread through 159 ...
(Date:4/28/2016)... ... April 28, 2016 , ... Next ... a talk on its first-in-class technologies for tissue stem cell counting and expansion ... RNAiMicroRNA Biology to Reprogramming & CRISPR-based Genome Engineering in Burlington, Massachusetts. , The ...
Breaking Biology Technology:
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/21/2016)... -- Unique technology combines v ...   Xura, Inc. (NASDAQ: ... communications services, today announced it is working alongside SpeechPro ... particularly those in the Financial Services Sector, the ability ... a mobile app, alongside, and in combination with, traditional ...
(Date:3/14/2016)... 14, 2016 NXTD ) ("NXT-ID" or ... market, announces the airing of a new series of commercials ... of March 21 st .  The commercials will air on ... Squawk on the Street show. --> NXTD ) ... mobile commerce market, announces the airing of a new series ...
Breaking Biology News(10 mins):